**Core tip:** Sleep deprivation affects brain activation, and therefore disturbs cognitive ability and reduces work efficiency. In the clinical field, night duty (ND) might affect surgical outcomes and the number of medical errors. In this study, we examined the influence of ND on endoscopic therapy for biliary duct stones. The procedure was significantly longer when performed by endoscopists after they had been on ND. The time required for endoscopic therapy for bile duct stones might be influenced by ND.

INTRODUCTION
============

Sleep deprivation disturbs cognitive ability, and sleep is important to maintain concentration\[[@B1]\]. Sleep deprivation also reduces work efficiency and changes brain activation\[[@B2]-[@B7]\]. However, most reports in the clinical field indicate that sleeping hours or night duty (ND) do not influence surgery. In Ellman et al\[[@B8]\] and Chu et al\[[@B9]\], sleeping hours did not affect outcomes after cardiac surgery. In Sharpe et al\[[@B10]\] complications and re-hospitalization 30 d after abdominal surgery (hernia repair, cholecystectomy, intestinal operations) did not differ significantly between doctors who were and were not on ND on the previous day. Most recently, Govindarajan et al\[[@B11]\] reported that prior night work did not affect outcomes for gastroenterology surgeries, hysterectomy, orthopedic surgeries, lung resection, craniotomy, or angioplasty. However, in Rothschild et al\[[@B12]\], complications were more frequent after surgery performed by surgeons with a prior sleep time of less than 6 h, and serious medical errors have been associated with interns working for more than 24 h\[[@B13]\].

Endoscopic therapy requires considerable concentration, but the dependence of outcomes on sleep time or ND has not been examined. Therefore, in this study, we investigated the influence of ND on endoscopic therapy for bile duct stones.

MATERIALS AND METHODS
=====================

Study design
------------

This study was performed as a retrospective analysis of clinical data. Written consent for endoscopic therapy was obtained from the patients. Informed consent for this study was not required. The ethics committee of Fukushima Medical University approved the study, and the details of the study are published on the homepage of Fukushima Medical University (authorization No. 2453).

Patients
--------

Among 335 patients treated with endoscopic therapy for bile duct stones from January 2011 to December 2015 at Fukushima Medical University Hospital, 167 underwent initial endoscopic therapy and had stones confirmed *via* computed tomography or endoscopic retrograde cholangiography (Figure [1](#F1){ref-type="fig"}). Among these patients, data from 133 patients treated by eight endoscopists (A-H) were evaluated in this study. In total, 34 patients were treated by an endoscopist after they had been on ND the previous day (ND group), and 99 patients were treated by the same endoscopists when they had not been on ND the previous day (day duty, DD group) (Table [1](#T1){ref-type="table"}). ND was defined as performing normal ward duties in the hospital overnight and sometimes examining emergency patients.

###### 

Profile of endoscopists

  **Item**                             **ND Group**   **DD Group**   ***P* value**
  ------------------------------------ -------------- -------------- ---------------
  Endoscopists (years of experience)                                 0.527
  A (14-19)                            5              11             
  B (6-9)                              7              17             
  C (6-8)                              8              21             
  D (6-11)                             5              16             
  E (7-12)                             2              22             
  F (10-15)                            3              7              
  G (5-8)                              3              4              
  H (3-7)                              1              1              
  Years of experience, mean ± SD       9.3 ± 3.9      9.4 ± 3.4      0.830

ND: Night duty; DD: Day duty.

![Disposition of patients in the study. Among 335 patients treated by endoscopic therapy for bile duct stones in five years at our hospital, 167 underwent initial endoscopic therapy. The data from 133 patients treated by eight endoscopists who sometimes worked night shifts were evaluated in this study. These 133 cases included 34 patients treated by endoscopists after they had been on night duty the previous day (ND group) and 99 treated by the same endoscopists when they had not been on night duty the previous day (DD group). ND: Night duty; DD: Day duty.](WJG-22-9387-g001){#F1}

Methods
-------

The following items were compared between the ND and DD groups: years of experience of the endoscopists, patient characteristics (age, gender, history of abdominal surgery, transverse diameter of the largest stone, number of stones), endoscopic procedure \[sphincterotomy (EST), papillary balloon dilation (EPBD), papillary large balloon dilation (EPLBD)\], treatment outcomes (procedure time; removal of stones by the first endoscopist; procedure success rate by the first endoscopist: removal of stones or endoscopic retrograde biliary drainage; final rate of stone removal; final procedure success rate; complications; and hospitalization after procedure). The outcomes related to the second (or more) endoscopist were included in the study: rate of final stone removal and final procedure success rate. History of abdominal surgery and treatment outcomes (procedure time, removal of stones, procedure success rate) were also compared between the two groups for each of the four endoscopists (A-D) who treated many of the patients in the ND group. The main outcome was a comparison of treatment results to evaluate the work efficiency in the ND and DD groups.

Endoscopic retrograde cholangiopancreatography (ERCP)-related procedures were performed for patients with stable breathing and hemodynamics. Before ERCP, patients were sedated with midazolam under observation of blood pressure and oxygen saturation. However, patients in septic shock were not sedated. Most procedures were performed with a JF 260V endoscope (Olympus, Tokyo, Japan). A Q260J (Olympus) was used for double tract reconstruction in proximal gastrectomy, a PCF-Q260AI or Q260J (Olympus) was used for Billroth II (B-II) procedures, and a PCF-Q260AL (Olympus) was used for Roux-en-Y (R-Y). For R-Y after choledocojejunostomy, the bile duct-jejunum anastomosis was accessed with a SIF-Q260 (Olympus) and a sliding tube. The balloon of the sliding tube was expanded, fixed and placed, and endoscopy with a PCF-PQ260AI (Olympus) was then performed through the sliding tube.

EST was performed using Clever Cut (Olympus). In cases in which it was difficult to cannulate the biliary duct, or for patients with a history of abdominal surgery, an RX needle knife XL (Boston Scientific, Tokyo, Japan) was used. EPBD was performed if the transverse diameter of the largest stone was \> 8 mm and bile duct stones were difficult to remove only by EST or if a perivaterian diverticulum was present. A Hurricane RX Biliary Balloon Dilation Catheter (Boston Scientific) was used for EPBD. EPLBD was performed if the transverse diameter of the largest stone was \> 12 mm, if many bile duct stones were difficult to remove only by EST or if sufficient EST was difficult because of a parapapillary diverticulum or history of abdominal surgery. A CRE Biliary Balloon Dilation Catheter (Boston Scientific) or a Giga (Century Medical, Tokyo, Japan) was used for EPLBD. A Trapezoid RX basket catheter (Boston Scientific) and a LithoCrush V, FG-V435P (Olympus) were used as tools to crush stones.

Statistical analysis
--------------------

Years of experience of endoscopists, patient age, transverse diameter of the largest stone, number of stones, and hospitalization after the procedure were compared by Student's *t* tests. The number of procedures performed by each endoscopist in the ND and DD groups, patient gender, history of abdominal surgery, EPLBD, rate of stone removal by the first endoscopist, rate of final stone removal and procedure success rate by the first endoscopist were compared by the *χ^2^* test. Procedure time was compared with the Welch *t* test. EST, EPBD, complications, final procedure success rate and items for each endoscopist (history of abdominal surgery, removal of stones rate, procedure success rate) were compared by the Fisher exact probability test. The procedure time for each endoscopist was compared by the Mann-Whitney *U* test. *P* \< 0.05 was considered to be significant. All analyses were performed using Statcel 3 (OMS Edition, Saitama, Japan).

RESULTS
=======

There were no significant differences regarding the number of treatments performed by each endoscopist or in the years of experience between the ND and DD groups (Table [1](#T1){ref-type="table"}). The frequency of ERCP did not differ significantly between the groups. There were also no significant differences in patient characteristics regarding age, gender, history of abdominal surgery (ND 7: Billroth II 4, R-Y 3; DD 18: double tract reconstruction 1, Billroth I 3, Billroth II 6, R-Y 7, duodenoduodenostomy for annular pancreas 1), transverse diameter of the largest stone, and number of stones between the two groups (Table [2](#T2){ref-type="table"}).

###### 

Comparison of patient characteristics

                                                             **ND Group**   **DD Group**   ***P* value**
  ---------------------------------------------------------- -------------- -------------- ---------------
  Age (yr), mean ± SD                                        73.1 ± 13.0    72.4 ± 14.3    0.801
  Gender (M/W)                                               21/13          59/40          0.824
  History of abdominal surgery, *n* (%)                      7 (20.6)       18 (18.2)      0.757
  Double tract reconstruction, *n*                                          1              
  Billroth I                                                                3              
  Billroth II                                                4              6              
  Roux-en-Y                                                  3              7              
  Duodenoduodenostomy                                                       1              
  Transverse diameter of the largest stone (mm), mean ± SD   10.6 ± 4.6     10.3 ± 4.9     0.735
  Number of stones, mean ± SD                                2.8 ± 4.0      2.8 ± 3.6      1.0

ND: Night duty; DD: Day duty; Double tract reconstruction: Double tract reconstruction for proximal gastrectomy; Duodenoduodenostomy: Duodenoduodenostomy for annular pancreas.

Among the treatment procedures, the rates of EST and EPBD did not differ significantly between the groups, but EPLBD was performed more frequently in the ND group \[47.1% (16/34) *vs* 19.2% (19/99)\] (Table [3](#T3){ref-type="table"}). Regarding outcomes, there were no significant differences in the rate of stone removal and procedure success rate, complications (ND: pancreatitis 1; DD: pancreatitis 6, duodenal bleeding 1, decreased blood pressure 1, hypoxia 2), or hospitalization after the procedure (Table [4](#T4){ref-type="table"}). However, the procedure time was significantly longer in the ND group (71.5 ± 44.7 *vs* 54.2 ± 28.8).

###### 

Comparison of endoscopic procedures, *n* (%)

          **ND Group**   **DD Group**   ***P* value**
  ------- -------------- -------------- ---------------
  EST     32 (94.1)      83 (83.8)      0.107
  EPBD    0 (0)          6 (6.1)        0.163
  EPLBD   16 (47.1)      19 (19.2)      0.001

ND: Night duty; DD: Day duty; EST: Endoscopic sphincterotomy; EPBD: Endoscopic papillary balloon dilation; EPLBD: Endoscopic papillary large balloon dilation.

###### 

Comparison of treatment outcomes *n* (%)

                                                   **ND Group**   **DD Group**   ***P* value**
  ------------------------------------------------ -------------- -------------- ---------------
  Procedure time (min), mean ± SD                  71.5 ± 44.7    54.2 ± 28.8    0.043
  Rate of stone removal by first endoscopist       13 (38.2)      52 (52.5)      0.150
  Procedure success rate by first endoscopist      18 (52.9)      57 (57.6)      0.638
  Rate of final stone removal                      24 (70.6)      66 (66.7)      0.67
  Final procedure success rate                     33 (97.1)      90 (90.9)      0.22
  Complications                                    1 (2.9)        11 (11.1)      0.136
  Pancreatitis                                     1              6              
  Duodenal bleeding                                               2              
  Decreased blood pressure                                        1              
  Hypoxia                                                         2              
  Hospitalization after procedure (d), mean ± SD   7.1 ± 7.6      6.6 ± 6.6      0.715

ND: Night duty; DD: Day duty; Procedure success rate: Removal of stones or biliary stenting.

For each of the four endoscopists A-D, there were no significant differences in patient history of abdominal surgery, rate of stone removal, and procedure success rate. However, the procedure time for endoscopist D was significantly longer in the ND group (Table [5](#T5){ref-type="table"}).

###### 

Comparison of treatment outcomes for each endoscopist *n* (%)

                                      **ND Group**   **DD Group**   ***P* value**
  ----------------------------------- -------------- -------------- ---------------
  Endoscopist A                                                     
  *n*                                 5              11             
  Procedure time (min), median ± SD   90.0 ± 80.8    90.0 ± 39.7    0.910
  Rate of stone removal               3 (60.0)       6 (54.5)       0.635
  Procedure success rate              5 (100)        9 (81.8)       0.458
  Endoscopist B                                                     
  *n*                                 7              17             
  Procedure time (min), median ± SD   40.0 ± 20.4    50.0 ± 26.0    0.589
  Rate of stone removal               5 (71.4)       11 (64.7)      0.572
  Procedure success rate              5 (71.4)       12 (70.6)      0.607
  Endoscopist C                                                     
  *n*                                 8              21             
  Procedure time (min), median ± SD   75.0 ± 39.6    50.0 ± 27.1    0.113
  Rate of stone removal               3 (37.5)       7 (33.3)       0.745
  Procedure success rate              4 (50.0)       10 (47.6)      0.617
  Endoscopist D                                                     
  *n*                                 5              16             
  Procedure time (min), median ± SD   60 ± 31.5      40 ± 14.7      0.017
  Rate of stone removal               1 (20)         8 (50)         0.258
  Procedure success rate              1 (20)         10 (62.5)      0.126

ND: Night duty; DD: Day duty; Procedure success rate: Removal of stones or biliary stenting.

DISCUSSION
==========

In this report, we examined the influence of ND on endoscopic therapy for bile duct stones. The rate of EPLBD and the procedure time were significantly greater for endoscopists after ND. The procedure time was also longer in the ND group for one endoscopist.

Although more EPLBD procedures were performed in the ND group, the patients who met the criteria for EPLBD described in the Materials and Methods were not significantly different between the ND group and the DD group according to the results of *χ^2^* tests (Table [6](#T6){ref-type="table"}). Fewer EPLBD procedures were performed in the DD group for several reasons. However, it has been shown that EPLBD shortens the procedure by allowing easier removal of stones or at least does not extend the procedure time\[[@B14],[@B15]\]. Based on these earlier reports, we suggest that EPLBD did not contribute to the longer procedure time in the ND group.

###### 

Reasons for not performing endoscopic papillary large balloon dilation

                                                                                     **ND Group**   **DD Group**   ***P* value**
  ---------------------------------------------------------------------------------- -------------- -------------- ---------------
  Patients with EPLBD indication, *n* (%)                                            20 (58.8)      44 (44.4)      0.15
  Patients in whom EPLBD was performed (shown in Table [3](#T3){ref-type="table"})   16             19             
  Reasons for not performing EPLBD                                                                                 
  AOSC                                                                               1              5              
  Narrow lower bile duct                                                             1              1              
  Biliary stricture                                                                  1              0              
  Minor bleeding of Vater's papilla                                                  1              0              
  No insurance coverage for EPLBD                                                    0              5              
  96 years old and performance status 3                                              0              1              
  Gallstone pancreatitis                                                             0              3              
  Antithrombotic drug therapy                                                        0              4              
  Difficulty identifying the biliary anastomotic region                              0              2              
  Smaller stones on visual inspection                                                0              2              
  Difficulty identifying the Vater papilla                                           0              1              
  Double tract reconstruction                                                        0              1              

EPLBD: Endoscopic papillary large balloon dilation; AOSC: Acute obstructive suppurative cholangitis.

The cause of the longer procedure time for endoscopists after ND might be the influence of sleep deprivation or lower sleep quality on work efficiency. The attention, vigilance, and driving tasks of residents during heavy night call rotations were equivalent to those for residents with a 0.04 to 0.05 g % blood alcohol concentration during a light call rotation\[[@B16]\]. Sanches et al\[[@B17]\] also found that the psychomotor performance of young doctors on night shifts was lower than that of young doctors who were not assigned night work. Thus, ND may influence the procedure time of endoscopic therapy for bile duct stones.

In this study, there was no significant difference in complications between procedures performed by endoscopists who had and had not been on prior ND, but an extended procedure time has been reported to be a risk factor for post-ERCP pancreatitis\[[@B18],[@B19]\]. In addition, Pan et al\[[@B20]\] found that a cannulation challenge to the common bile duct within 10 min gave the best results in trials by trainees. Therefore, if a procedure is slow by an endoscopist working after ND, it might be advisable to change the endoscopist.

There are several limitations to this study, including its retrospective design and the small number of cases of ERCP for bile duct stones at a single institution. We perform 400 ERCP procedures each year. However, in this study, we only included patients treated by endoscopists who had been on ND and performed the initial endoscopic therapy for bile duct stones. This resulted in a small number of eligible subjects. However, restricting the endoscopic procedures to the treatment of bile duct stones allowed for a more precise evaluation of the influence of ND compared to previous studies that considered the effect of ND on multiple types of surgery\[[@B8]-[@B12]\]. Secondly, we did not measure the exact sleep time of the endoscopists. However, night shifts and on-call duty have been found to influence circadian rhythm and worsen quality of sleep\[[@B21],[@B22]\]. A difference in bedding also influences quality of sleep\[[@B23]-[@B26]\], and, therefore, ND itself is likely to influence quality of sleep. Thirdly, we were unable to compare the number of biliary duct cannulation challenges between the two groups to evaluate the direct influence of ND on the endoscopic procedure due to a lack of precise records. A further study of the number of biliary duct cannulations is desirable.

Within these limitations, we conclude that the procedure time for endoscopic therapy for bile duct stones is increased by the influence of ND. Substitution of an endoscopist after ND might be advisable to shorten the procedure.
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Background
----------

Concentration was affected by sleep deprivation. Recently, sleep deprivation or night duty (ND) was reported to influence several medical activities. However, the relationship between endoscopic therapy and sleep deprivation or ND was uncertain.

Research frontiers
------------------

Endoscopic therapy for bile duct stones requires much concentration. In Japan, many endoscopists perform endoscopic therapy after ND. This study clarified the influence of ND on endoscopic therapy for bile duct stones.

Innovations and breakthroughs
-----------------------------

There have been no reports about the influence of ND on endoscopic therapy. In this report, ND the previous day influenced the procedure time for endoscopic therapy for bile duct stones.

Applications
------------

This study suggested that ND the previous day influenced the procedure time of endoscopic therapy for bile duct stones. According to this result, if the first endoscopist who was on ND the previous day experiences difficulty in the endoscopic procedure, it is advisable to change endoscopists earlier.

Terminology
-----------

ERCP: endoscopic procedure that contrasts biliary duct and pancreatic duct using X-ray equipment; EST: endoscopic procedure that incises the papilla of Vater; EPBD: endoscopic procedure that dilates the biliary exit to remove the stones; EPLBD: endoscopic procedure that dilates the biliary exit using a large balloon catheter to remove large stones or many stones.
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